Friday, September 29, 2017

Life Sciences CEOs Bracing For Artificial Intelligence

Delivering double digit growth for large drug makers is rare. KPMG's survey found that 93 percent of life sciences CEOs expect annual revenue growth ...
Delivered by KPMG Today (@KPMG_TO)
Article continues here
Follow @KPMG_TO on Twitter to get latest updates